These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 2229288

  • 1. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D.
    Shaker JL, Krawczyk KW, Findling JW.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1305-9. PubMed ID: 2229288
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels.
    Wortsman J, Haddad JG, Posillico JT, Brown EM.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1305-8. PubMed ID: 3754562
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH, Garon J, Lepage R, Gascon-Barré M, D'Amour P.
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [Abstract] [Full Text] [Related]

  • 5. New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
    Yonemura K, Suzuki H, Fujigaki Y, Hishida A.
    Am J Med Sci; 2000 Nov; 320(5):334-6. PubMed ID: 11093687
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
    Kinoshita Y, Taguchi M, Takeshita A, Miura D, Tomikawa S, Takeuchi Y.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
    [Abstract] [Full Text] [Related]

  • 12. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
    Räkel A, Brossard JH, Patenaude JV, Albert C, Nassif E, Cantor T, Rousseau L, D'Amour P.
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA, Zysset E, Jenzer A, Thiébaud D, Ammann P, Rizzoli R, Jaquet-Müller F, Bonjour JP, Gertz B, Burckhardt P.
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.